Objectives. Neuropsychiatric (NP) involvement is a poorly understood manifestation of SLE. We studied post-mortem histopathology in relation to clinical NPSLE syndromes and complement deposition in brains of NPSLE and SLE patients and controls. Furthermore, we investigated the correlation between cerebral post-mortem histopathology and ex vivo 7 T MRI findings in SLE and NPSLE.
Introduction
SLE is a severe autoimmune disease characterized by circulating autoantibodies and immune complexes. SLE can manifest in virtually any organ system [1] . Nervous system involvement in SLE is commonly referred to as neuropsychiatric SLE (NPSLE) [2] and occurs in 1080% of patients [37] . NPSLE can present with a variety of symptoms that are frequently underrecognized despite being associated with increased morbidity and mortality [8, 9] . Because NPSLE is clinically heterogeneous, and because we lack aetiological insight and evidencebased therapies, the clinical management is complex.
As part of the clinical workup of a putative NPSLE patient, MRI of the brain plays a prominent role [10] , although interpretation of scans is often hampered by the so-called clinicoradiological paradox, by which some patients with SLE and severe neurological symptoms exhibit no or nonspecific abnormalities on MRI. In an analysis of MRI findings of 74 NPSLE patients, 42% had no MRI abnormalities despite having clinically active cerebral disease. Otherwise, white matter hyperintensities were most commonly found, which has been suggested to represent cerebral hypoperfusion and infarction [11] .
The few studies to date regarding the histopathology of NPSLE have revealed that most lesions are related to ischaemic injury in the vicinity of small-diameter vessels [1216] . Specifically, microthrombosis, microinfarction and microbleeds were generally found. Whereas SLE is characterized by autoantibody-mediated inflammation, these findings suggest a thromboischaemic pathogenesis. Thus far, studies in patients have failed to explain the interaction between autoantibody-mediated inflammation and thromboischaemic lesions in NPSLE. Given the recent evidence that classical complement activation corresponds with the presence of glomerular microthrombi in LN [17] and other thrombotic microangiopathies [1822], we hypothesized that complement activation may also underlie thromboischaemic injury observed in brains of NPSLE patients.
In a nationwide study using cerebral autopsy material from NPSLE, SLE and control cases, we examined postmortem histopathology in relation to clinical NPSLE syndromes and complement deposition. Furthermore, to evaluate whether histopathological lesions could be detected clinically, we investigated the correlation between cerebral post-mortem histopathology and ex vivo 7 T MRI in SLE and NPSLE.
Methods

Cerebral tissues
We conducted a nationwide search for cerebral autopsy tissue from SLE patients with and without clinical signs of neuropsychiatric (NP) involvement autopsied between 1971 and 2010 using the Dutch PALGA (PathologischAnatomisch Landelijk Geautomatiseerd Archief) database, a histo-and cytopathology network and archive to which all pathology laboratories within The Netherlands contribute [23] . We excluded patients who had cutaneous or discoid lupus only and included all patients with SLE according to the ACR revised criteria [24, 25] .
Clinical data were collected by contacting the rheumatologists at the different locations where the patients had been hospitalized. Because banking of sera and cerebrospinal fluid (CSF) was not routinely performed as part of the clinical workup for the patients, analysis of these materials was not feasible. SLE patients were divided into groups by two rheumatologists with extensive experience in diagnosing NPSLE (G.M.S.B. and T.W.J.H.): patients with NP syndromes attributed to SLE (NPSLE group) and patients without NP syndromes attributed to SLE (SLE group). The presence of NP syndromes in each patient was evaluated following the ACR definitions [2] and the existence of secondary factors causing these manifestations was assessed.
Controls were identified from the archives of the Leiden University Medical Centre and the Reinier de Graaf Hospital (Delft, The Netherlands) and included previously healthy patients who died of an acute cardiac event (confirmed at autopsy) between 2006 and 2009.
Histopathology and immunohistochemistry
Sections were stained with haematoxylin and eosin using standard protocols, and for the complement components C1q (classical pathway), Mannose Binding Lectin (MBL, lectin pathway), C4d and C5b-9 (membrane attack complex). Deparaffinized sections were subjected to antigen retrieval using Tris-EDTA (pH 9.0), 10 mM citrate buffer (pH 6.0) or proteinase (bacterial, type XXIV; SigmaAldrich, St Louis, MO, USA). The sections were then stained with antibodies against C1q (Dako Cytomation, Denmark; 1:800), C4d (Biomedica Gruppe, Austria; 1:50), MBL (Sigma-Aldrich Biotechnology; 1:500) and C5b-9 (A239; Quidel, San Diego, CA, USA; 1:500). Staining was visualized using the appropriate secondary antibodies with diaminobenzidine as chromagen. Finally, sections were counterstained with haematoxylin. Optimal antibody dilutions and incubation times were pre-determined empirically by titration experiments using positive controls.
Histopathological and immunohistochemical evaluation
All sections were evaluated by a neuropathologist (S.G.vD.) who was blinded with respect to clinical data. Each case was scored for the presence of microinfarction, macroinfarction, large haemorrhage, microbleeds, cerebral infection, vasculitis and vasculopathy. Infarction was defined as a sharply delimited region of cellular death or tissue necrosis, sometimes with cavitation, and was distinguished from microinfarction by the ability to detect this lesion by gross inspection [26] . Infarction could be observed in the absence of (micro)thrombi. Microthrombi were defined as microscopic clumps of fibrin, platelets and erythrocytes [27] . Microbleeds were defined as small (<5 mm) perivascular hemosiderin deposits (usually within macrophages), generally associated with local vessel wall damage. Large haemorrhage was defined as rupture of the blood vessel wall and extravasation of erythrocytes without inflammation in acute stages and oedema, ischaemia, infiltration of neutrophils, haemosiderin-laden macrophages and necrosis in later stages [27] . Vasculitis was defined as an inflammatory infiltrate and destructive change in the blood vessel wall [27] . In contrast, vasculopathy was defined as endothelial cell proliferation, thickening of the vessel wall and narrowing of the capillary lumen without an inflammatory infiltrate [15] . Vasculopathy was scored semi-quantitatively as absent [<10% of vessels with vasculopathy per low-power field (LPF)], focal (1050% of vessels with vasculopathy per LPF) or diffuse (>50% of vessels with vasculopathy in every LPF).
The immunohistochemically stained sections were scored by two independent observers who were blinded to the clinical data. C1q and C4d primarily stained endothelial cells of small vessels in the white and grey matter and were scored as absent (<10% of small vessels per LPF), focal (1050% of small vessels per LPF) or diffuse (>50% of small vessels in every LPF). C5b-9 similarly stained vessels, as well as cells with the morphology of glial cells, thus scoring for vessels was performed similar to C1q and C4d. Because MBL did not stain vessels, MBLpositive cells were scored as either present or absent.
Whole formalin-fixed brains: clinical case histories From three patients, whole formalin-fixed brains were available, enabling a direct comparison between postmortem ex vivo MRI and cerebral histopathology. Patient 1 was a 57-year-old female with NPSLE, APS and severe cerebrovascular disease. Patient 2 was a 38-year-old male with NPSLE, acute neurological deterioration and vasculitis. Patient 3 was a 63-year-old female with SLE without NP symptoms who suffered an acute myocardial infarction. Detailed case histories are provided as supplementary data, section 'Case histories', available at Rheumatology Online.
Post-mortem neuroimaging and evaluation
The procedure of post-mortem 7 T MRI scanning is detailed in the supplementary data, section 'Post-mortem neuroimaging and evaluation of the acquired images', available at Rheumatology Online. MRI scans were reviewed by two neuroradiologists with extensive experience in the field of NPSLE (M.A.vB. and B.J.E.), who then identified areas of interest.
After radiological analysis, tissue from areas of interest was sampled, embedded in paraffin and stained with haematoxylin and eosin. The neuropathologist reported the histopathological changes in each sample.
Ethical considerations
The ethics committee of the Leiden University Medical Center approved this study (P02.028). In accordance with the Dutch national ethics guideline (Code for Proper Secondary Use of Human Tissue, Dutch Federation of Medical Scientific Societies), all tissue samples and patient data were coded and kept anonymous throughout the study.
Statistical analyses
Categorical variables were compared using the chi-square test and its trend version for ordered categories (linearby-linear analysis). Correlations between histopathological variables were assessed by calculation of Pearson or Spearman correlation coefficients, as appropriate.
All analyses were performed using SPSS Statistics 23.0 (IBM, Armonk, NY, USA). P-values <0.05 were considered significant.
Results
Our nationwide search for cerebral autopsy tissue of SLE patients yielded 296 hits. Of these, 48 fulfilled our inclusion criteria. From 14 of these patients, paraffin blocks were no longer available or tissue quality was unsuitable for analysis. Thus formalin-fixed tissue samples from 34 SLE patients (27 females, 7 males) autopsied between 1981 and 2009 were retrieved from 12 Dutch pathology laboratories and used for analysis. Twenty-four patients who died of an acute cardiac event were included as controls. Table 1 provides an overview of clinical characteristics of NPSLE, SLE and control cases.
Three patients in the SLE group had NP syndromes that were attributed to factors other than SLE. Specifically, one patient suffered intracerebral haemorrhage associated with anticoagulant therapy, one patient had a severe cerebral mycotic infection associated with high-dose immunosuppression for LN and one patient died in a uraemic coma following acute renal failure secondary to LN.
Histopathology
The majority of histopathological lesions were located in the cerebral cortex, distributed equally across the white and grey matter. The patient groups (NPSLE and SLE) differed significantly from the controls with respect to all histopathological parameters. Microinfarction (P = 0.016), macroinfarction (P = 0.002) and vasculitis (P < 0.050) were more frequent in NPSLE patients than SLE patients. Microthrombi were found exclusively in NPSLE patients (P = 0.002 vs the other groups). Histopathological findings in the three groups are shown in Fig. 1 . The presence and distribution of vasculopathy differed between the three groups (linear-by-linear association; P < 0.001; Fig. 2 ). Typical examples of vasculopathy and cerebral microthrombi are shown in Fig. 3A and B, and correlations between neuropathological lesions in SLE and NPSLE patients are shown in the supplementary data, section 'Correlations between neuropathological lesions in patients with SLE and NPSLE', available at Rheumatology Online.
Vasculitis was found in six patients (five NPSLE, one SLE; P < 0.050). Each NPSLE patient with vasculitis also had vasculopathy (four diffuse, one focal). Vasculitis was associated with cerebrovascular disease in four NPSLE patients and with acute confusional state in one NPSLE patient. The patient from the SLE group with vasculitis had a severe mycotic infection associated with immunosuppressive therapy.
www.rheumatology.oxfordjournals.org Immunohistochemistry Figure 3CJ shows typical examples of immunohistochemical staining with C1q, C4d, MBL and C5b-9 in patients and controls. C1q, C4d and C5b-9 were observed on endothelial cells of small vessels (Fig. 3D, F and J) . Table 2 indicates that SLE and NPSLE patients showed more vascular C1q, C4d and C5b-9 staining than controls. Additionally, C5b-9 was observed on cells with the morphology of glial cells (Fig. 3I) . Cellular staining of C5b-9 was not different between patients and controls (data not shown). MBL deposits did not stain vessels, thus co-localization between MBL and C1q or C4d did not occur. Instead, MBL-positive staining was observed on cells resembling astrocytes. These MBL-positive cells ( Fig. 3G and H) were detected in both patients and controls (no difference; data not shown). 
1308 (177) 1290 (137) 1437 (171) a Eleven NPSLE patients had one syndrome, four patients had two syndromes and one patient had three syndromes.
FIG. 1 Histopathological lesions in (NP)SLE patients and controls
Frequency of the indicated lesions in brain tissue of SLE patients (n = 18), NPSLE patients (n = 16) and control subjects (n = 24). Microthrombi, microinfarctions, macroinfarctions and vasculitis were present more often in the brains of patients in the NPSLE group than in patients in the SLE group (*P < 0.05 vs SLE). None of the seven parameters were present in the brains of control patients.
FIG. 2 Vasculopathy in (NP)SLE patients and controls
Results of semi-quantitative scoring of vasculopathy in brain tissues of SLE patients (n = 18), NPSLE patients (n = 16) and control subjects (n = 24). Diffuse vasculopathy was present more often in the NPSLE brains than in SLE and control brains. *P < 0.05. 
Complement deposition in relation to histopathological findings in SLE and NPSLE
We investigated the relationship between C1q, C4d, C5b-9 and the presence of microthrombi, microinfarctions, macroinfarctions, vasculitis and vasculopathy. Only microthrombi were associated with C4d and C5b-9 staining (P = 0.047 and P = 0.020, respectively). Every patient with microthrombi also had either focal or diffuse C4d and C5b-9 staining. C4d and C5b-9 were strongly associated with microthrombi within the NPSLE group (P = 0.024 and P = 0.008, respectively).
Relationship between C4d, C1q and C5b-9 in SLE and NPSLE
To gain additional insight into the cascade of events in classical complement activation, the staining patterns of C1q, C4d and C5b-9 were related to one another in the SLE and NPSLE patient groups. In general, diffuse C1q staining was present more often than diffuse C5b-9 and C4d staining (35, 21 and 15%, respectively). Supplementary Table S1 , available at Rheumatology Online, shows that the distributions of C1q, C4d and C5b-9 were quite similar in the SLE and NPSLE groups.
Post-mortem ex vivo MRI in relation to histopathology
The results of post-mortem ex vivo MRI scans and histopathology findings of two NPSLE patients and one SLE patient are shown in Fig. 4 .
Patient 1
MRI revealed extensive confluent periventricular and deep white matter lesions with notable sparing of U-fibres (Fig. 4, patient 1 A and B) . Furthermore, central lacunae in the deep white matter suggested tissue loss consistent with lacunar infarction. White matter lesions around confluent white matter lesions and adjacent to deep white matter lesions were perivascular in distribution. Sections taken from both the deep and periventricular white matter lesions revealed areas of recent and less recent microinfarctions and macroinfarctions. In one deep white matter lesion, multiple microthrombi (Fig. 4 , patient 1 C and D) were identified. In all sections, prominent vasculopathy in grey and white matter was found (Fig. 4, patient 1  E) . Vasculopathy was present within white matter hyperintensities and infarcted areas, as well as in normal-appearing white and grey matter. Furthermore, vast areas of atrophied cortex-particularly in the proximity of infarctions-had laminar necrosis (Fig. 4, patient 1 F) .
Patient 2
MRI revealed normal grey and white matter differentiation (Fig. 4, patient 2 G and H) . Several linear hyperintensities were characteristic of normal VirchowRobin spaces (Fig. 4, patient 2 G) . Unlike patient 1, the white matter was homogeneous and cortical thickness was normal.
Because no abnormalities were identified on MRI, sections were obtained from several cortical areas. Each of these revealed diffuse vasculopathy (Fig. 4 , patient 2 I and J). Furthermore, lymphocytes had invaded vascular walls of several veins and venules, reflected by the presence of fragmented nuclei and fibrinoid material (Fig. 4, patient 2  K) . No intravascular microthrombi, infarctions or gliosis were identified.
Patient 3
MRI revealed a prominent VirchowRobin space (Fig. 4,  patient 3 L) . In addition, a linear perivascular white matter www.rheumatology.oxfordjournals.org hyperintensity was present in the internal capsule. Another white matter lesion was identified in the frontal white matter (Fig. 4, patient 3 M) .
Sections taken from the frontal white matter lesion revealed focal vasculopathy. No other abnormalities were identified. Vasculopathy was present in a similar focal distribution pattern throughout all sections (Fig. 4 , patient 3 N and O).
Discussion
In this study we described the injury in brains of patients with NPSLE as compared with SLE and control cases in relation to classical complement deposition. We identified a number of histopathological lesions that were specific to NPSLE and could thus be linked to clinical NPSLE manifestations as defined by the ACR [2] . Compared with SLE patients, NPSLE patients showed significantly more microinfarction, macroinfarction, vasculitis and microthrombi, although in controls these and other neuropathological abnormalities were absent. Also, diffuse vasculopathy occurred significantly more often in NPSLE than in SLE, whereas focal vasculopathy was found in all groups. The common finding of vasculopathy and the absence of a relationship with acute clinical NPSLE are in accordance with previous findings [15] . Our data show that the injury and clinical manifestations of NPSLE represent a continuum ranging from relatively non-specific lesions found in most SLE patients, such as focal vasculopathy, to specific and even pathognomonic lesions in this setting, including diffuse vasculopathy and microthrombi associated with clinical syndromes defining NPSLE [2] .
Our study is the first to demonstrate that deposits of the classical complement components C1q and C4d, as well as the terminal complement complex (C5b-9), are concurrently present in the cerebral vessels of patients with NPSLE and SLE significantly more often than in controls. This constellation of staining patterns indicates that activation of the classical complement pathway proceeded to completion, as demonstrated by the formation of the terminal complement complex. The role of complement activation in the development of thrombosis and ischaemia has been studied extensively outside the field of SLE, where complement has been linked to microthrombotic injury in APS [19, 22] and thrombotic microangiopathy [18] . In these conditions, accumulation of antibodies in small vessels most likely leads to activation of the classical complement pathway, endothelial injury and the subsequent formation of microthrombi [18] . Given that vasculopathy, microinfarction, macroinfarction, vasculitis and microthrombi may all evoke vascular occlusion and could thereby result in clinical abnormalities, the question arises as to why some of these lesions were found to be more specific in our study for NPSLE than others. Our findings suggest that thromboischaemic injury may occur in all SLE patients, but that overt NPSLE ensues only after a certain threshold of complement-mediated injury is reached. The finding that, of all vascular lesions, only microthrombi were correlated with C4d and C5b-9 suggests that microthrombi represent a more progressed stage of complement-mediated injury. Conceivably, microthrombi were also present in patients with subclinical NPSLE, although in smaller quantities, and would therefore be more readily missed in these cases due to sampling error.
Although cerebral vasculitis is generally considered to be rare in NPSLE, we identified five NPSLE patients (31%) with vasculitis. This relatively high incidence as compared with previous studies [1215] may be explained by our clear distinction of SLE and NPSLE cases. In four of the NPSLE patients with vasculitis, vasculitis was associated with cerebrovascular disease. Interestingly, our neuropathological analyses revealed that vasculitis was correlated with large haemorrhage. Although according to the recommendations for the management of NPSLE cerebrovascular disease due to ischaemic stroke and/or transient ischemic attack comprises >80% of cases and therefore does not require immunosuppression [10] , we showed that vasculitis may still be an underlying factor in a substantial number of cases. Our findings emphasize that immunosuppressive therapy may occasionally be indicated in cases with a component of vasculitis All values given as n (%). C1q: NPSLE vs controls, P < 0.001; SLE vs controls, P < 0.001; NPSLE vs SLE, P = 0.531. C4d: NPSLE vs controls, P < 0.001; SLE vs controls, P < 0.001; NPSLE vs SLE, P = 0.801. C5b-9: NPSLE vs controls, P < 0.001; SLE vs controls, P < 0.001; NPSLE vs SLE, P = 0.796. *Chi-square test.
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underlying cerebrovascular disease as a manifestation of NPSLE. Diamond et al.
[2830] focused on the role of autoantibodies in the development of NP symptoms in a murine model and found that anti-dsDNA antibodies derived from human SLE patients can cross-react with N-methyl-D-aspartate receptors on neurons causing neuronal death by excitotoxicity and apoptosis. However, in subsequent studies in which these antibodies were induced in mice, neuronal damage occurred solely when a breach in the bloodbrain barrier was present [31, 32] . Our findings may indicate that continuously exposing the cerebral endothelium to autoantibodies can cause complement activation and endothelial injury in all SLE patients. Possibly a second hit is required to develop overt clinical disease in the form of NPSLE [2] . Infection, pregnancy, drug toxicity and defects in complement regulation have all been described as triggering factors [20, 21] . Possibly, these evoke a breach in the bloodbrain barrier together with the formation of C4d-and C5b-9-associated microthrombi, as well as the other lesions we identified that were distinctive of NPSLE. Since sera and CSF were not available from the patients in our study, it was not possible to further analyse the antibody profile in CSF and the CSF:albumin ratio as possible indicators of bloodbrain barrier integrity in concert with the assessment of thromboischaemic injury in NPSLE and SLE patients. Whether these or other factors affecting the integrity of the bloodbrain barrier play a role in NPSLE will be the subject of future studies.
Apart from the clinicopathological paradox of impressive histopathological cerebral lesions that were sometimes not accompanied by overt clinical NPSLE, we were also confronted with the clinicoradiological paradox. In contrast to the clinicopathological paradox, the latter is defined by the absence of abnormalities on conventional MRI in patients with clinical NPSLE, and this hampers assessment of the extent of cerebral injury in NPSLE [11] . We investigated whether microvascular and thromboischaemic injury could be detected clinically by analysing three whole brains of SLE patients using 7 T MRI. High field MRI can provide images at higher spatial resolution, resulting in more detailed information regarding microvascular injury compared with conventional MRI. Interestingly, for these brains even high field MRI was unable to detect most small vessel injury that was visible histopathologically. The microvascular injury that could be detected was most prevalent in the vicinity of white matter hyperintensities. On the other hand, high field MRI could detect non-specific lesions more readily than conventional MRI [33] . White matter hyperintensities by conventional MRI may be found in 20% of the general population <50 years of age and in 90% of people >70 years of age [33] . Furthermore, white matter lesions may be observed in SLE patients who do not have NP symptoms. Indeed, white matter lesions were detected in one SLE patient without NPSLE by 7 T MRI in our study, in association with focal vasculopathy. Thus, although white matter hyperintensities may indicate an initial phase of vascular damage in some SLE patients, they should generally be considered non-specific. Probably more sensitive as well as more specific imaging tools are required for the diagnosis of NPSLE. Future studies to determine the feasibility of quantitative techniques such as volumetric magnetization transfer imaging [34, 35] to detect specific lesions in SLE and NPSLE patients are called for, as brain biopsies remain unattainable in routine clinical practice.
In conclusion, NPSLE is a poorly understood manifestation of SLE associated with significant morbidity and mortality. NPSLE is usually treated with aggressive immunosuppression, which can be beneficial in some-but certainly not all-NPSLE patients [10, 36] . Our finding that complement activation is present in both SLE and NPSLE suggests that this mechanism may contribute to the development of injury. It remains to be elucidated whether the clinical manifestations of NPSLE following injury are due to a thromboischaemic pathomechanism, due to a breach in the bloodbrain barrier facilitating antibodymediated neuroinflammation or due to a combination of both. Importantly, our novel finding of complement in association with injury in SLE and NPSLE proposes the complement system as a promising new therapeutic target in NPSLE. The finding that C5b-9 deposits were present in 82% of patients with SLE and NPSLE in our study suggests that this proportion of patients with NPSLE-and perhaps also SLE-may benefit from treatment with the terminal complement inhibitor eculizumab [3742] . The efficacy of such treatment in NPSLE and SLE remains to be investigated.
Funding: No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article. Efficacy of intra-articular corticosteroid injection in erosive hand osteoarthritis: infrared thermal imaging A 64-year-old woman with long-standing erosive hand OA (EHOA; Fig. 1A and B) presented with a painful flare in the first IP joint of the right hand. Using an infrared thermal camera (Fig. 1C) we detected a higher temperature in the thumb skin (maximal and minimal temperatures 34.5 and 33.8 C, respectively; mean 34.2 C) compared with the other fingers (maximal and minimal temperatures 32.1 and 31.1 C, respectively; mean 31.3 C). She was treated with an intra-articular US-guided injection of triamcinolone acetonide (20 mg) in the first IP joint. Two weeks later the infrared thermal evaluation (Fig. 1D ) revealed a robust decrease in the mean temperature of the first IP joint skin (maximal and minimal temperatures 31.7 and 30.5 C, respectively; mean 31.1 C) as well as of the other fingers and the whole hand, together with a marked improvement of pain.
EHOA is considered a variant of hand OA with severe local inflammation and degeneration of the distal and proximal IP joints [1] . Digital infrared thermal imaging is a non-invasive, safe and reproducible technique for mapping the thermal pattern of the body [2] that can be used to monitor the efficacy of local treatment in EHOA.
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